This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Design of PEG-grafted-PLA nanoparticles as oral permeability enhancer for P-gp substrate drug model Famotidine.
Journal of microencapsulation · 2017
Insomnia Symptoms Following Treatment for Comorbid Panic Disorder With Agoraphobia and Generalized Anxiety Disorder.
The Journal of nervous and mental disease · 2016
Carboxymethyl starch mucoadhesive microspheres as gastroretentive dosage form.
International journal of pharmaceutics · 2015
Latest funding
- $522,495
Generalized anxiety disorder in older adults : Efficacy of a self-help treatment guided by trained lay providers
CIHR · 2017 · Principal investigator
4 publications.
Design of PEG-grafted-PLA nanoparticles as oral permeability enhancer for P-gp substrate drug model Famotidine.
Mokhtar M, Gosselin P, Lacasse F, Hildgen P
Insomnia Symptoms Following Treatment for Comorbid Panic Disorder With Agoraphobia and Generalized Anxiety Disorder.
Cousineau H, Marchand A, Bouchard S, Bélanger C, Gosselin P, Langlois F, Labrecque J, Dugas MJ, Belleville G
Carboxymethyl starch mucoadhesive microspheres as gastroretentive dosage form.
Lemieux M, Gosselin P, Mateescu MA
Self-exclusion program: a longitudinal evaluation study.
Ladouceur R, Sylvain C, Gosselin P
Generalized anxiety disorder in older adults : Efficacy of a self-help treatment guided by trained lay providers
Principal investigators: Landreville, Philippe; Gosselin, Patrick; Grenier, Sébastien
Keywords: Aging; Generalized Anxiety Disorder; Treatment
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.